Sec. 702. Enhancing regulatory transparency to enhance generic competition
69 words·~1 min read·
/bill/115/hr/2430/rh/section-702A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 505(j) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) is amended by adding at the end the following: Upon the request of an applicant regarding one or more specified pending applications under this subsection, the Secretary shall— by telephone or electronic mail, provide review status updates; and indicate in such updates the categorical status of the applications by each relevant review discipline. .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 702
Enhancing regulatory transparency to enhance generic competition
Cites 1Cited by 0 across 0 sources